Clinical Study

Reduced ErbB4 Expression in Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis

Table 1

Study Participants.

ParticipantsBlood donors ( )Age (yrs)Female: male

All RR MS patients1834.7 ± 14.212 : 6
Untreated patients732.1 ± 8.55 : 2
Interferon- -treated patients1136.2 ± 9.97 : 4
Healthy controls1535.6 ± 6.810 : 5